Johansen PB, Nowak J, Skjaerbaek C, Flyvbjerg A, Andreassen TT, Wilken M, Orskov H
WHERE IT TREATS Pituitary gland, cellular metabolism, and body composition
For understanding side effects, see GLP-1 side effects
For years, insurers dismissed weight loss as cosmetic
GLP-1 receptor agonists (also known as glucagon-like peptide-1 agonists) are a popular class of medications used in conjunction with a reduced-calorie diet and exercise to help manage Type 2 diabetes and support weight loss in individuals with obesity
Not only does that aggravate supply issues for people with true medical conditions who depend on these drugs, there are risks